Meridiem Capital Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.4M Buy
226,542
+46,059
+26% +$8.47M 1.9% 15
2026
Q1
$34.1M Buy
180,483
+154,632
+598% +$32.6M 2.22% 15
2025
Q4
$5.14M Buy
+25,851
New +$5.22M 0.31% 64
2025
Q1
Sell
-23,427
Closed -$2.96M 93
2024
Q4
$2.96M Buy
+23,427
New +$3.48M 0.26% 63

Other funds holding THC

Meridiem Capital Partners's THC Position: Q2 2026 in Review

Meridiem Capital Partners increased its Tenet Healthcare (THC) stake by 26% in Q2 2026, buying an estimated $8.47M and bringing the position to 226,542 shares worth $42.4M. The position accounts for 1.9% of the portfolio, ranked #15.

Meridiem Capital Partners first reported a position in THC in Q4 2024 and has held it in 4 quarters since. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Meridiem Capital Partners held 226,542 shares of Tenet Healthcare worth $42.4M as of Q2 2026.
  • Meridiem Capital Partners bought 46,059 Tenet Healthcare shares in Q2 2026, an estimated $8.47M.
  • Tenet Healthcare made up 1.9% of Meridiem Capital Partners's portfolio in Q2 2026, its #15 holding.
  • Meridiem Capital Partners first reported a position in Tenet Healthcare in Q4 2024 and has held it in 4 quarters since.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Meridiem Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.